Medicare Enrolled
Dr. Cyril Tawa, M.D.
Cardiovascular Disease · Cypress, TX
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tawa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tawa?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tawa
Dr. Cyril Tawa is a cardiovascular disease specialist in Cypress, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Tawa performed 6,868 Medicare services across 4,044 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tawa received a total of $8,819 from 40 pharmaceutical and/or device companies across 416 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tawa is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 9% volume in TX
$8,819 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,868
Medicare services
Top 9% in TX for cardiovascular disease
4,044
Unique beneficiaries
$150
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~361 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,808 | $91 | $200 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,018 | $11 | $95 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
876 | $44 | $300 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
547 | $29 | $195 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
354 | $138 | $754 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
296 | $1 | $10 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
252 | $57 | $300 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 214 | $701 | $1,362 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
213 | $1,952 | $4,500 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
159 | $65 | $300 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
144 | $147 | $500 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
115 | $143 | $600 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
89 | $4 | $15 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
85 | $111 | $262 |
| Physician review of home INR testing A physician reviews, interprets, and manages home INR testing results for patients with mechanical heart valves, chronic atrial fibrillation, or venous thromboembolism who meet Medicare coverage criteria. |
79 | $7 | $25 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
76 | $23 | $50 |
| Cardiac rhythm monitor evaluation Review and analysis of data recorded by a cardiac rhythm monitoring device to assess heart activity. |
73 | $37 | $75 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording, analyzing, and interpreting a continuous external electrocardiogram (EKG) over a period of more than 48 hours up to 7 days. |
61 | $208 | $800 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
60 | $44 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
55 | $64 | $155 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
51 | $18 | $82 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
43 | $105 | $215 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
39 | $137 | $200 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
38 | $10 | $20 |
| Cardiac catheterization | 24 | $188 | $1,500 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
20 | $66 | $112 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
19 | $141 | $552 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
18 | $225 | $500 |
| Insertion of implantable heart rhythm monitor A small device is placed under the skin to continuously record the heart's electrical activity. This helps detect irregular heart rhythms that may not appear during a standard office visit. |
17 | $3,557 | $10,000 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
13 | $479 | $3,200 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
12 | $166 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.0% high complexity
21.2% medium
66.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,819
Total received (2018-2024)
Avg $1,260/year across 7 years
Top 35% in TX for cardiovascular disease
40
Companies
416
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,799 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$954
2023
$1,339
2022
$1,476
2021
$1,303
2020
$781
2019
$1,376
2018
$1,590
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$1,404
Amgen Inc.
$1,049
Janssen Pharmaceuticals, Inc
$894
Boston Scientific Corporation
$745
E.R. Squibb & Sons, L.L.C.
$530
Medtronic, Inc.
$384
Astellas Pharma US Inc
$351
Boehringer Ingelheim Pharmaceuticals, Inc.
$328
PFIZER INC.
$322
Medtronic Vascular, Inc.
$301
Novartis Pharmaceuticals Corporation
$294
Amarin Pharma Inc.
$275
AstraZeneca Pharmaceuticals LP
$217
Merck Sharp & Dohme LLC
$193
Gilead Sciences, Inc.
$156
SANOFI-AVENTIS U.S. LLC
$143
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$131
BOSTON SCIENTIFIC CORPORATION
$105
Lundbeck LLC
$104
NOVARTIS PHARMACEUTICALS CORPORATION
$95
Edwards Lifesciences Corporation
$91
Kowa Pharmaceuticals America, Inc.
$89
Regeneron Healthcare Solutions, Inc.
$82
Esperion Therapeutics, Inc.
$70
Kiniksa Pharmaceuticals, Ltd.
$50
CARDIVA MEDICAL, INC.
$48
ARBOR PHARMACEUTICALS, INC.
$48
Impulse Dynamics (USA) Inc.
$43
Azurity Pharmaceuticals, Inc.
$42
AGEPHA Pharma FZ LLC
$35
Actelion Pharmaceuticals US, Inc.
$34
Recor Medical Inc
$25
Preventice Services, LLC
$25
Itamar Medical Inc
$25
BIOTRONIK INC.
$20
CVRx, Inc.
$18
Aziyo Biologics, Inc.
$15
AtriCure, Inc.
$14
Arbor Pharmaceuticals, Inc.
$14
SCPHARMACEUTICALS INC.
$14
Top 3 companies account for 37.9% of total payments
Associated products mentioned in payments ›
AZURE XT DR MRI SURESCAN · Arcalyst · Assurity Pacemaker · Azure · BG Mini Plus · BRILINTA · Barostim Neo System · BodyGuardian · CAMZYOS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · CONFIRM RX · CareLink · Claria MRI · Confirm Rx · Connectivity and Remote care · CoreValve Evolut · Corlanor · ECM · EDARBI · EDARBYCLOR · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FUROSCIX · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · JARDIANCE · LEQVIO · LEXISCAN · LINQ II · LIVALO · LODOCO · LUX DX · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · Livalo · MITRACLIP · MRI Ready Leads · MULTAQ · MYCARELINK · Merlin Connectivity and Remote · Micra · Mitra Clip system · NEXLETOL · NORTHERA · OPSUMIT MACITENTAN · Optimizer · Optimizer Smart System · PARADISE RENAL DENERVATION SYSTEM · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · QUADRA ASSURA · QUARTET · Quartet CRT Lead · RESONATE · REVEAL LINQ · Repatha · Resolute · Reveal LINQ · SAPIEN 3 Ultra RESILIA · UPTRAVI · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WatchPAT · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $128 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
199
Per 100K population
4.2
County median income
$73,104
Nearest hospital
LONE STAR BEHAVIORAL HEALTH CYPRESS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Tawa is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 9% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Tawa experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Tawa performed 1,808 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tawa receive payments from pharmaceutical companies?
Yes. Dr. Tawa received a total of $8,819 from 40 companies across 416 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tawa's costs compare to other cardiologists in Cypress?
Dr. Tawa's average Medicare payment per service is $150. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tawa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Cypress
Browse cardiologists in Cypress ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology